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Abstract
Background: Inflammatory processes play important roles in both neuropathic and inflammatory
pain states, but the effects of inflammation per se within the sensory ganglia are not well
understood. The cytokine growth-related oncogene (GRO/KC; CXCL1) shows strong, rapid
upregulation in dorsal root ganglion (DRG) in both nerve injury and inflammatory pain models. We
examined the direct effects of GRO/KC on small diameter DRG neurons, which are predominantly
nociceptive. Whole cell voltage clamp technique was used to measure voltage-activated potassium
(K) currents in acutely cultured adult rat small diameter sensory neurons. Fluorescently labeled
isolectin B4 (IB4) was used to classify cells as IB4-positive or IB4-negative.
Results: In IB4-negative neurons, voltage-activated K current densities of both transient and
sustained components were increased after overnight incubation with GRO/KC (1.5 nM), without
marked changes in voltage dependence or kinetics. The average values for the slow and fast decay
time constants at 20 mV were unchanged by GRO/KC. The amplitude of the fast inactivating
component increased significantly with no large shifts in the voltage dependence of inactivation. The
increase in K currents was completely blocked by co-incubation with protein synthesis inhibitor
cycloheximide (CHX) or NF-κB inhibitors pyrrolidine dithiocarbamate (PDTC) or quinazoline (6-
Amino-4-(4-phenoxypheny lethylamino;QNZ). In contrast, the voltage-activated K current of IB4-
positive neurons was unchanged by GRO/KC. GRO/KC incubation caused no significant changes
in the expression level of eight selected voltage-gated K channel genes in quantitative PCR analysis.
Conclusion: The results suggest that GRO/KC has important effects in inflammatory processes
via its direct actions on sensory neurons, and that activation of NF-κB is involved in the GRO/KC-
induced enhancement of K currents.
Background
Inflammatory processes are recognized to play key roles in
chronic pain. The traditional distinction between inflam-
matory and nerve injury models of chronic pain has been
recently augmented by the recognition that even nerve
injury models have inflammatory components. Many
cytokines and chemokines with previously established
roles in the immune system have also been found to have
direct effects on peripheral and central neurons, and to
play key roles in pathologic pain [1-3]. One such chemok-
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ine is Growth-Related Oncogene (GRO/KC; systemic
name CXCL1). We first became interested in this molecule
because it was very strongly and rapidly upregulated in
DRG in several different pain models, including the spinal
nerve ligation model [4] and a model in which pain
behaviors are evoked by localized inflammation of the
DRG [5].
GRO/KC is well known for its role in neutrophil chemo-
taxis and degranulation early during inflammation. In
this regard its effects are similar to those of other CXC
family cytokines such as interleukin-8 (IL-8; CXCL8) in
humans [6]. GRO/KC may also have direct roles in the
nervous system, including roles in pathological pain. Both
GRO/KC and its primary receptor, CXCR2 (IL-8Rb) are
expressed in neurons and other cells in the central nervous
system, under both normal and pathological conditions
[7-13]. In the peripheral nervous system, GRO/KC stimu-
lates calcium influx [14], and release of the pain-related
peptide calcitonin gene-related peptide (CGRP) [15] from
cultured neonatal DRG neurons. Levels of GRO/KC in
inflamed muscle tissue correlate well with nociceptive
behavior [16]. In general, these studies in peripheral nerv-
ous system suggest a pro-nociceptive role for GRO/KC
(however, see [17]).
Previously we have described a rat pain model in which
localized inflammation of the DRG (LID) is induced by
depositing a small drop of the immune stimulator
zymosan over the L5 DRG. This leads to prolonged
mechanical pain behaviors, and a rapid increase in levels
of GRO/KC and other pro-inflammatory cytokines [5] in
the DRG. We have also demonstrated that LID causes
marked increases in excitability, large increases in Na cur-
rents and, to a lesser degree, K currents [18] in small diam-
eter DRG neurons as observed with patch clamp methods
after acute culture. In that study, TTX-sensitive Na currents
increased 2 to 3 fold in both IB4-positive and IB4-negative
cells, while TTX-resistant Na currents increased over 2-fold
but only in IB4-positive cells. Transient K currents
increased over 2-fold, while sustained K currents showed
a very modest though significant increase. The observed
increases in Na and K current densities were due to
increased amplitude, not to large shifts in voltage depend-
ence of activation or inactivation; the increase in transient
K current was due to increased amplitude of the faster-
inactivating current of two kinetically distinct compo-
nents. In a second study [19], we found that some of these
effects on Na currents could be mimicked by overnight
incubation with GRO/KC (1.5 nM). Overnight GRO/KC
treatment in acutely cultured neurons led to increased
excitability, and to 2- to 4 fold increases in TTX-resistant
and TTX-sensitive Na currents (in both IB4-positive and
IB4-negative cells) without altered voltage dependence or
kinetic changes. Changes in Na current were blocked by a
protein synthesis inhibitor, and we observed increases in
mRNA abundance of particular Na channel isoforms that
are already present in control cells. The results suggested
that GRO/KC may have important pro-nociceptive effects
through direct effects on neurons, and were consistent
with the idea that some though not all of the changes
observed after LID in vivo might be mediated by this
chemokine. In the present study we have extended this
line of research to study the in vitro effects of GRO/KC on
voltage-activated K currents, as these were also increased
by local DRG inflammation. We have also begun to exam-
ine possible signaling pathways by which GRO/KC might
effect these changes in neuronal properties.
Methods
Animals
Young female Sprague-Dawley rats (body mass 100–150
g) were housed one or two -per cage under a controlled
diurnal cycle of 12 h light and 12 h dark with free access
to water and food. The ambient environment was main-
tained at constant temperature (22 ± 0.5°C) and relative
humidity (60–70%). All the surgical procedures and the
experimental protocol were approved by the institutional
animal care and use committee of the University of
Cincinnati (Cincinnati, Ohio, USA).
Acute culture of sensory neurons
Rats were anesthetized by intraperitoneal injection of
pentobarbital sodium (50 mg/kg). The bilateral L4 and L5
DRGs were isolated and the sheath was carefully removed
in ice-cold normal Ringer solution. The connective tissue
was digested by exposure to Ca2+-free solution containing
1.0% collagenase II (Fisher Scientific, Pittsburgh, Pennsyl-
vania, USA) for 30 min at 37°C followed by washout in
normal Ringer solution for another 10 min. DRGs were
then dissociated by trituration with fire-polished Pasteur
pipettes. DRG cells were plated onto poly-D-lysine coated
glass coverslips in Medium199 (Sigma, St. Louis, Mis-
souri, USA) containing 10% heat-inactivated FBS and
1000 U/ml each of penicillin and streptomycin. GRO/KC
(rat recombinant, from Cell Sciences, Canton, Massachue-
setts, USA and PeproTech, Rocky Hill, New Jersey, USA)
and/or other drugs were added to the medium immedi-
ately after plating or as indicated, and the DRG cells were
incubated at 37°C (5% CO2 balance air). Recordings were
made after overnight culture and drug incubation (16–24
hours), and cells were selected for recording based on
diameter (< 25 μm) and the absence of processes. Isolec-
tin B4 (IB4) 1 μg/μl (conjugated to FITC; Sigma) was
added to the culture medium for 30–60 min prior to the
start of recording sessions to identify IB4-postive (prima-
rily non-peptidergic) and IB4-negative (primarily pepti-
dergic) neurons [20,21]. This procedure has been
previously shown not to affect the currents measured [22].
Neurons showing a robust fluorescence signal were classi-Molecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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fied as IB4-positive and those displaying no signal at all,
IB4-negative. We have previously shown that GRO/KC
incubation does not alter the fraction of cells that is IB4-
positive [19]; hence in some cases IB4-status was deter-
mined before recording from a cell in order to obtained
matched sets of data. Throughout each individual experi-
ment, we alternated between recording from control and
experimental cells during the recording period so as to
compare control and experimental cells taken from the
same cultures. For experiments in which there were four
experimental groups (e.g. GRO/KC, GRO/KC plus drug,
control, control plus drug), only two groups were exam-
ined per culture. Some sets of cultures were used to deter-
mine the effects of drug on GRO/KC treated cells, and
different sets were used to determine the effects of the
drug on control cells in the absence of GRO/KC.
Drugs were applied at the following concentrations: GRO/
KC 1.5 nM, Pyrrolidine dithiocarbamate (PDTC, Sigma)
50 μM, Quinazoline (QNZ, Calbiochem) 100 nM (stocks
made with ethanol and control cells treated with vehicle),
cycloheximide (Sigma), 3.55 μM.
Electrophysiological recording
After over-night culture (16–24 hours), coverslips were
transferred to a recording chamber. Whole cell voltage-
clamp recordings of small DRG neurons (diameter 15–25
μm) were conducted at room temperature with an Axo-
Patch-200B amplifier (Molecular Devices Corp, Union
City, California, USA). Patch pipettes (2.5–4.0 MΩ) were
fabricated from borosilicate glass. Data were acquired on
a Pentium IV computer with the Clampex 8 program
(Molecular Devices Corp). The cell capacitance artifact
was canceled by the nulling circuit of the recording ampli-
fier. Voltage errors were minimized by using ≥ 80% series
resistance compensation. The current was filtered at 5 kHz
and sampled at 50 kHz. The recording chamber was con-
tinuously perfused at room temperature with oxygenated
bath solution at a flow rate of 1–2 ml/min.
Resting membrane potential was measured 1 min after a
stable recording was obtained. Current pulses from -0.2 to
0.4 nA (80-ms pulse duration) were delivered in incre-
ments of 0.03 nA until one or more APs were evoked.
Neurons were selected for further study if they had a rest-
ing membrane potential that was more negative than -45
mV and if they exhibited overshooting action potentials.
The bath solution was then switched to that used for
measuring K current (see below). Total K current was
measured by depolarizing voltage steps after a 1-s pre-
pulse to -120 mV. The difference between the peak current
and the current at the end of the pulse was used as a meas-
ure of the transient K current, and the current at the end of
the pulse was used as a measure of the sustained current.
Voltage dependence of inactivation was measured by test
pulses to 20 mV after 1-s prepulses to voltages between -
100 and 0 mV.
Solutions for recording potassium currents
The normal bath solution contained 130 mM NaCl, 5 mM
KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10
mM glucose. The pH was adjusted to 7.4 with NaOH, and
the osmolarity was adjusted to approximately 300–310
mOsm with sucrose. After the whole cell configuration
was established and current clamp measurements of excit-
ability and resting potential were completed, the bath
solution was changed to one used for recording K cur-
rents, which contained 130 mM choline Cl, 5 mM KCl, 1
mM MgCl2, 2 mM CoCl2, 10 mM HEPES, and 10 mM glu-
cose. The pH was adjusted to 7.4 with Tris base, and the
osmolarity was adjusted to approximately 300–310
mOsm with sucrose. The pipette solution contained 140
mM KCl, 1 mM CaCl2, 2 mM MgCl2, 11 mM EGTA, 10
mM HEPES, 2 mM Mg adenosine triphosphate, and 1 mM
Li guanosine triphosphate. The pH was adjusted to 7.2
with Tris base, and osmolarity was adjusted to approxi-
mately 290–300 mOsm with sucrose. Voltages were not
corrected for liquid junction potentials, which were esti-
mated to be less than 10 mV in all cases.
Data analysis and statistics
Data were analyzed using Clampfit 9 (Molecular Devices
Corp), Graphpad Prism (GraphPad Software, Inc., San
Diego, California, USA), Origin 7 (Origin Lab Corp.,
Northampton, Massachusetts, USA), and SigmaStat (Sys-
tat Software, Inc., San Jose, California, USA). Currents
were normalized by cell capacitance. Data are expressed as
mean ± standard error of the mean (SEM). Statistical sig-
nificance of differences between average values in experi-
mental and control neurons was analyzed by Student's t-
test or, for data that were not normally distributed, the
Mann-Whitney rank sum test. In the case of multiple com-
parisons over a voltage range for activation or inactivation
data, the data were analyzed by two-way repeated meas-
ures ANOVA (RM ANOVA), with pairwise multiple com-
parison (Holm-Sidak method) to determine at which
voltages the differences between experimental and control
cells were significant if an overall effect of GRO/KC or
drug treatment was observed. Significance was ascribed
for P < 0.05.
Quantitative PCR
Total RNA was isolated from DRG cultures under condi-
tions similar to those used in electrophysiological record-
ings, using a Stratagene Absolutely RNA Microprep Kit
(Stratagene, La Jolle, California. USA). Immediately after
isolation, RNA was reverse transcribed into cDNA using
an iScript cDNA kit (Bio-Rad, Hercules, California USA).
Cells treated overnight with 1.5 nM GRO/KC were com-
pared with control cells from the same animal. RelativeMolecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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channel expression was determined by quantitative PCR
using a Stratagene MX-Pro 3005P. cDNA samples were
amplified in triplicate (10 min at 95°C, followed by 40
cycles of 30 s 95°C, 60 s 60°C, then 60 s 72°C, followed
by a 60 s step to 76°C for SYBR green fluorescence meas-
urement) in a 25 μl reaction volume (400 nM each for-
ward and reverse primers, SYBR green reaction mix (Roche
Applied Science, Indianapolis, Indiana, USA)). Fluores-
cence was normalized with the reference dye ROX, and
gene expression was normalized to the housekeeping gene
hypoxanthine ribosyltransferase (HPRT; [23]), run on the
same plate. Primers were selected using the Primer3 pro-
gram [24] and were designed to include exon-intron
boundaries to minimize contamination by genomic
DNA, except for the intronless Kv1.3. Primers were exam-
ined with an in silico virtual PCR program to ensure that
no other products were predicted from rat cDNA or
genomic DNA http://genome.ucsc.edu, and/or by blast-
ing the predicted PCR products against the rat reference
mRNA sequence database. PCR products were verified by
melting point analysis at the end of each experiment, and,
during protocol development, by gel electrophoresis.
Template from control cells was run side-by-side with
template from GRO/KC-treated cells from the same cul-
ture. The baseline calculation, threshold, threshold cycle,
and efficiencies of the amplification reactions were esti-
mated directly from the reference-dye normalized ampli-
fication plots using the LinReg program and a correction
for efficiencies was included in the relative expression cal-
culations [25]. Efficiencies were generally similar for con-
trol and GRO/KC treated samples, and across
experiments; a single efficiency value was used for control
and GRO/KC samples for each gene. Forward and reverse
primer sequences used for the genes listed in Table 1[26]
are available in Additional file 1.
Results
Incubation with GRO/KC enhances voltage-gated K 
currents in IB4-negative cells
Voltage-activated K currents were recorded as shown in
Figure 1. The membrane was held at -60 mV, and voltage
steps were applied in 10 mV increments up to a value of
+60 mV after a 1s prepulse to -120 mV. The total K current
was comprised of sustained components, as measured at
the end of the 500-ms pulse, and transient components
which largely decayed during the pulse. In view of the
complexity and variability of K currents in DRG neurons
[27-29], and for comparison with our previous studies
[18,19], we analyzed the effects of GRO/KC incubation on
these two components, the transient (IA) and the sus-
tained (IK). The transient component did not always com-
pletely decay during the 500 ms pulse; however, we
determined that estimating the steady state (sustained)
current from the extrapolated constant value of two-expo-
nential fits to the falling phase of the current resulted in
only a minor correction in most cells, and did not change
the overall results reported here (data not shown; see
[18]).
The current densities of both transient (P < 0.001) and
sustained components (P < 0.001) were increased after
overnight incubation with GRO/KC (1.5 nM) in IB4-neg-
ative neurons (Figure 2). Two-way repeated-measures
analysis of variance indicated that the effect of GRO/KC
was significant at all points above 10 mV in IB4-negative
cells. These effects were primarily due to increased ampli-
tude of the current, without any large changes in the volt-
age dependence of activation (Figure 3); however, the
activation curve for the transient component showed a
small (5.5 mV) but significant leftward shift after GRO/
KC incubation.
Table 1: Quantitative PCR measurements of selected voltage-gated K channels
Channel Type* Rat gene symbol Rat Gene ID Abundance in control cells relative to
Kv 1.1
Fold-change w/GRO/KC
Kv 1.1 DR Kcna1 [GenBank: 24520] 1.00 ± 0.17 1.18 ± 0.12
Kv 1.2 DR Kcna2 [GenBank: 25468] 0.25 ± 0.04 1.24 ± 0.19
Kv 1.3 DR Kcna3 [GenBank: 29731] 0.06 ± 0.04 0.81 ± 0.23
Kv 1.4 A-type Kcna4 [GenBank: 25469] 0.16 ± 0.11 0.82 ± 0.22
Kv 3.1 DR Kcnc1 [GenBank: 25327] 0.02 ± 0.00 1.14 ± 0.20
Kv 3.4 A-type Kcnc4 [GenBank: 684516] 0.05 ± 0.00 1.11 ± 0.09
Kv 4.3 A-type Kcnd3 [GenBank: 65195] 0.06 ± 0.01 0.89 ± 0.05
MinK-2 accessory Kcne3 [GenBank: 63883] 0.02 ± 0.00 0.98 ± 0.15
N = 4 cultures from 4 animals, each of which provided a pair of RNA samples (control cells and GRO/KC treated cells). All expression values were 
normalized to that of the housekeeping gene HPRT from the same sample; fold changes (GRO/KC/control) were calculated for each individual pair 
of matched samples. For comparison of relative abundance of channel types in control cells, expression data were normalized to the most abundant 
channel observed, Kv1.1. None of the fold-change values after overnight GRO/KC incubation was significantly different from 1.
*, channel type as given by reference [26], "DR" = delayed rectifier; however, K channel properties may also depend on accessory proteins and 
heteromer composition.Molecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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There was no significant change in K current density in
IB4-positive neurons after GRO/KC incubation (Figure 2).
In subsequent figures we show results only from IB4-neg-
ative neurons. However, all experiments shown were also
conducted in IB4-positive neurons. These experiments
simply confirmed the original findings; we did not
observe significant differences due to GRO/KC or any
drug treatment between any of the experimental groups in
IB4-positive cells. The apparently greater density of the
transient and sustained currents in control IB4-positive
cells compared to control IB4-negative cells (Figure 2) was
not statistically significant.
In the course of these experiments we also replicated our
previously published results [19] showing that GRO/KC
incubation led to decreased rheobase and lowered action
potential threshold in IB4-negative cells, and that the cells
acquired the ability to fire repetitively throughout the
course of a prolonged current injection.
The voltage dependence of steady state inactivation was
also determined for the voltage-activated K currents. The
protocol consisted of a 1-s conditioning prepulse to
potentials ranging between -100 and 0 mV followed by a
voltage step to a +20 mV test pulse for 1 s. As in our previ-
ous study [18], the decay of the outward current at +20
mV could be well described in most cells as the sum of a
sustained component and two exponentially decaying
transient components whose time constants differed by
an order of magnitude. The average values for the slow
and fast time constants in IB4-negative cells were
unchanged by GRO/KC (1100.1 ± 254 ms.1 vs. 861.3 ±
154.2 ms, and 62.4 ± 7.8 ms vs. 57.6 ± 4.8 ms, respec-
tively; Figure 4). Fast and slow time constants in IB4-pos-
itive cells were also not significantly changed by GRO/KC
incubation, and did not differ significantly from those
observed in IB4-negative cells.
The steady state inactivation of each of these three compo-
nents was studied individually by fitting the data at the
+20 mV test pulse with the sum of two exponentials plus
a constant (steady state) value, as in our previous study
[18]. As shown in Figure 5, in IB4-negative cells the fast
inactivating (middle panel) component showed a simple
increase in amplitude after GRO/KC (P = 0.04), with no
significant shift in the voltage dependence of inactivation.
For the slow inactivating component and steady state
component (Figure 3), the amplitudes were numerically
increased, but this difference was not significant (P = 0.71
and 0.44, respectively), and the voltage dependence was
not affected.
Enhancement of K currents by GRO/KC is blocked by a 
protein synthesis inhibitor
The finding that GRO/KC enhanced the magnitude of K
currents in IB4-negative cells, without marked shifts in
voltage dependence of activation or kinetics suggested
that the primary effect might be an increased number of K
channels, and hence that protein synthesis might be
required. To test this idea, we conducted experiments
using the protein synthesis inhibitor cycloheximide. The
results are shown in Figure 6. In general, cycloheximide
prevented the GRO/KC-induced increases in K current
density, without significantly affecting baseline current
densities (P = 0.755). In IB4-negative cells, the only signif-
icant differences observed were between the GRO/KC
treated groups and all other groups.
Effects of GRO/KC are blocked by NF-κB inhibitors
Two NF-κB inhibitors, pyrrolidine dithiocarbamate
(PDTC) and quinazoline (6-Amino-4-(4-phenoxypheny
lethylamino), QNZ) were used to explore the possible sig-
naling pathway of GRO/KC effects on K currents. PDTC or
QNZ was added 1 h before GRO/KC and was present
Voltage activated K currents of DRG neurons in IB4-negative  cells Figure 1
Voltage activated K currents of DRG neurons in IB4-
negative cells. Currents shown were evoked by depolariz-
ing pulses from -60 to + 60 mV. Examples are shown from a 
control cell (A) and from a GRO/KC incubated cell (B). The 
difference between the peak current (1) and the current at 
the end of the pulse (2) was used as a measure of the tran-
sient K current.Molecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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throughout the incubation period. Both PDTC and QNZ
blocked the effects of GRO/KC on K currents. Neither had
effect on K currents in control cells (P = 0.867 and 0.999,
respectively) (Figure 7).
Quantitative PCR analysis of selected K channels
The electrophysiological experiments suggested that the
increase in K current in IB4-negative cells after GRO/KC
incubation was not due to the appearance of new chan-
nels with novel properties not seen in control cells. Qual-
itatively consistent with this idea, quantitative PCR
experiments on selected voltage activated K channels did
not reveal any types that were present only after GRO/KC
analysis (Table 1). However, we did not examine all the
possible genes coding for K currents that might mediate
the delayed rectifier or A-type currents observed.
Discussion
In this study we found that overnight incubation with
GRO/KC (CXCL1), a chemokine that is rapidly upregu-
lated in the DRG in several different models of chronic
pain, caused upregulation of K current amplitudes in
Voltage activated K current in IB4-negative dorsal root ganglion neurons increased after GRO/KC incubation Figure 2
Voltage activated K current in IB4-negative dorsal root ganglion neurons increased after GRO/KC incubation. 
The current densities of both the transient component and sustained components were increased after overnight incubation 
with GRO/KC (1.5 nM) in IB4-negative neurons. *, the effect of GRO/KC was significant at all points above 10 mV (left). There 
was no significant effect in IB4-positive neurons (right). Data are from 5 cultures; in IB4-negative neurons, N = 15 GRO/KC and 
16 control cells; in IB4-Positive neurons, N = 16 GRO/KC and 15 control cells.Molecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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acutely isolated small diameter IB4-negative DRG neu-
rons in short-term culture. This upregulation required
protein synthesis and activation of NF-κB. Many studies
on the role of chemokines in pain conditions, including
GRO/KC (e.g., [30]), have focused on their indirect effects
on neurons, via stimulation of release of inflammatory
mediators from immune and glial cells that then act on
sympathetic and sensory neurons. Since our cultures are
relatively sparse, and we record primarily from isolated
neurons with few or no glial cells attached, it seems most
likely that the effects of GRO/KC incubation on K currents
were due to direct effects on the neurons. Our previous
study indicated that GRO/KC receptors are found on both
IB4-positive and IB4-negative neurons in acute culture
(and in vivo), and that GRO/KC can have important pro-
nociceptive effects via its direct actions on sensory neu-
rons [19].
We observed effects on K currents at a relatively low GRO/
KC concentration of 1.5 nM, which is well within the
physiological range for most peptide receptor actions and
within the range of concentrations reported to be effective
at the CXCR2 receptor [15]. This concentration was cho-
sen based on our previous study, in which we demon-
strated that incubation with 1.5 nM GRO/KC but not
lower concentrations (0.06 or 0.28 nM) caused significant
upregulation of Na currents.
Effect of GRO/KC treatment on voltage-dependence of K  current activation in IB4-negative cells Figure 3
Effect of GRO/KC treatment on voltage-dependence 
of K current activation in IB4-negative cells. Data from 
Figure 2 were converted to conductance values using the cal-
culated value of the K Nernst potential. Data were fitted 
with the Boltzmann equation. Top: the transient component 
showed a small but significant leftward shift of V1/2, from 14.3 
mV in control cells to 8.8 mV in GRO/KC treated cells (p < 
0.0005). The Hill slope values were 10.3 and 11.7 mV, 
respectively (for e-fold change; difference not significant). 
Bottom: there was no significant change in the voltage 
dependence of activation of the sustained component. Best-
fit shared parameters were -9.3 mV for V1/2 and 15.1 mV for 
Hill slope.
Inactivation time constants at +20 mV are not affected by  GRO/KC incubation Figure 4
Inactivation time constants at +20 mV are not 
affected by GRO/KC incubation. The falling phase of the 
currents at a test pulse of +20 mV following prepulses 
between -100 and 0 mV was fitted with the sum of two 
exponentials. The time constants for the slow and fast com-
ponents were not significantly changed by GRO/KC incuba-
tion.Molecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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Potassium currents have important roles in modulating
neuronal excitability. Previous studies described three
major components of voltage-gated potassium current in
small sensory neurons, including non-inactivating current
and fast and slow transient currents as we have analyzed
here [27,29,31-33]. However, this is undoubtedly an over-
simplification; for example, one study delineated six com-
ponents of K current, five of which were in small diameter
neurons such as studied here [28]. K channel genetic
diversity suggests a possibly larger number, especially
given the existence of functionally distinct heteromers and
splice variants in the several gene families that mediate
voltage-activated K currents [34]. Our preliminary quanti-
tative PCR study indicated that all seven of the delayed
rectifier and A-type (inactivating) channels as well as the
regulatory accessory protein MinK-P2 that we selected for
study were readily observed in our acute DRG cultures.
The method was not sensitive enough to detect upregula-
tion of particular channels that might account for our
electrophysiological results, though this is perhaps not
surprising given the relatively small increase that would
be expected (2-fold or less increases in current density
occurring in less than half of the cells present in the cul-
tures). The expression results confirmed that, qualitatively
consistent with the electrophysiological findings, GRO/
KC incubation did not induce marked upregulation of a K
channel gene with distinct properties that was absent in
control cells. However, it should be noted that we looked
at only 8 genes, not every gene known to possibly mediate
the types of K currents measured.
Effects of GRO/KC on the fitted two exponential fits to steady state inactivation data Figure 5
Effects of GRO/KC on the fitted two exponential fits to steady state inactivation data. The falling phase of currents 
during a pulse to +20 mV after a prepulse to the indicated voltage was fit with the sum of two exponentials plus a steady state 
value. At this test voltage, most cells show two kinetically distinct components of the transient K current. The values of the 
amplitudes of each component are normalized to the value at -100 mV (top): left, slow inactivating; middle, fast inactivating; 
right, steady state component. The bottom panels show the corresponding absolute values of the fitted amplitudes. * Individual 
voltages at which the differences between GRO/KC and control values were significant. Data in this and previous figures are 
from 5 cultures; N = 12 GRO/KC cells and 11 control cells.Molecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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The most robust effect of GRO/KC in this study was the
relatively large increase (aprox. 2 fold) in amplitude of the
faster-inactivating component of the transient K current.
(This may correspond to IAf and/or Iht in the paper by Gold
et al., given that our measurements were at +20 mV where
these components have similar decay time constants.) The
complex forms of the averaged steady state inactivation
curves we observed even when dividing the K current into
fast-inactivating, slow-inactivating, and constant compo-
nents (Fig 5) suggest that multiple channel types are
present. Within the context of the simplified analysis used
here, the effect on the transient K current is qualitatively
quite similar to that observed in our previous study of the
effects on localized DRG inflammation on K currents
([18]; see Introduction). However, that study did not
divide cells into IB4-positive and IB4-negative cells, yet
still showed over 2 fold increases in magnitude of the
faster inactivating component, whereas in the present
study a similar increase was observed in IB4-negative cells
with no increase in IB4-positive cells. Since IB4-negative
cells comprise about half of the population of small cells
under our culture conditions, it seems that the observed
effects of GRO/KC are consistent with the effects of local-
ized inflammation on transient K currents, but are not suf-
ficient to account for all those effects quantitatively.
In contrast, the effects of GRO/KC incubation on sus-
tained K currents were much more modest, and unlikely
to play a role at physiological voltages. This increase was
significant in IB4-negative cells when currents were exam-
ined from a -120 mV prepulse (Fig 2), but not from more
positive prepulses going into the physiological range (Fig
5). These effects on sustained K current are very similar to
those observed after LID [18]. Calcium-activated K cur-
rents were not examined in the current study because of
the presence of EGTA in the recording pipette and Co2+
replacing Ca2+ in the extracellular solution.
Potassium channel reduction is thought to contribute to
the increased excitability and generation/patterning of
spontaneous activity in sensory neurons following
peripheral nerve injury [35-37]. Potassium currents are
not always reduced under pathological conditions; they
may be upregulated as recently described by our group in
a pain model induced by localized inflammation of the
DRG [18]. In that model, both potassium currents and
sodium currents are increased in small DRG neurons after
a localized inflammation, and the increase in Na current
density is quite large (2-fold or more). It seems likely that
it is the balance of effects on Na and K (and other cur-
rents) which determines the net effect on excitability.
Our previous study of effects of GRO/KC incubation on
excitability parameters [19] showed that many measures
of excitability were increased by GRO/KC in both IB4-neg-
ative and IB4-positive cells. However, two differences
between the two subtypes were that IB4-negative cells
showed a more marked increase in the ability to fire repet-
itively, as well as an increase in the after-hyperpolariza-
tion. Hence it is interesting that only these IB4-negative
cells showed an increase in transient K currents, which can
play a role in making repetitive firing possible [38,39].
However, it should be noted that other currents not exam-
ined in this study may also play a role in determining the
afterhyperpolarization and repetitive firing, such as the
hyperpolarization-activated current IH [40], calcium-acti-
vated K-currents [41], and the kinetic properties of the var-
ious Na channel subtypes [42].
The protein synthesis inhibitor cycloheximide (CHX)
completely blocked the effects of GRO/KC on K currents,
which indicated that protein synthesis is required for the
effect on K currents. The simplest explanation would be
Treatment with the protein synthesis inhibitor cycloheximide  (CHX, 3.5 μM) blocked the effects of GRO/KC on K cur- rents in IB4-negative cells Figure 6
Treatment with the protein synthesis inhibitor 
cycloheximide (CHX, 3.5 μM) blocked the effects of 
GRO/KC on K currents in IB4-negative cells. CHX had 
no effect on K currents in control cells (P = 0.755). CHX was 
added at the same time as GRO/KC and was present 
throughout the incubation period. GRO (N = 19) and 
GRO+CHX (N = 18) cells were from 9 cultures; 12 control 
cells and 8 CHX cells were from 2 cultures.Molecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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that additional K channels are synthesized after GRO/KC
incubation, as this would be consistent with the observa-
tion that primarily it is the magnitudes of some compo-
nents of the K currents are altered, not their activation
ranges or decay time constants. However, there may be
other possibilities such as synthesis of proteins that mod-
ulate channels already present. GRO/KC actions are
thought to be mediated by the CXCR2 receptor, a G-pro-
tein-coupled receptor, which has been shown to activate a
number of different signaling pathways in neurons,
including intracellular Ca2+, inositol tris-phosphate, MAP
kinases, and CREB [43]. All of these pathways can lead to
enhanced transcription and protein synthesis through a
number of signal transduction pathways.
Nuclear factor kappa B (NF-κB) is a transcription factor
which serves as a transducer between extracellular signals
and gene expression. We chose this pathway for initial
study because of its key role in inflammation, and showed
that pretreatment with either of two NF-κB inhibitors,
The NF-κB inhibitors pyrrolidine dithiocarbamate (PDTC) and quinazoline (6-Amino-4-(4-phenoxypheny lethylamino), QNZ)  blocked the effects of GRO/KC on K currents Figure 7
The NF-κB inhibitors pyrrolidine dithiocarbamate (PDTC) and quinazoline (6-Amino-4-(4-phenoxypheny 
lethylamino), QNZ) blocked the effects of GRO/KC on K currents. QNZ was dissolved in Ethanol. PDTC or QNZ 
was added 1 h before GRO/KC and was present throughout the incubation period. Neither PDTC nor QNZ had an effect on 
K currents in control cells (P = 0.867 and 0.999, respectively). *, significantly different from all other groups at this voltage. In 
PDTC experiments, GRO/KC (N = 18 cells), GRO/KC+PDTC (N = 18) were from 4 cultures, control (N = 13) and PDTC (N 
= 11) were from 4 cultures; in QNZ experiments, GRO/KC (N = 26), GRO/KC+QNZ (N = 26) were from 7 cultures, control 
(N = 6) and QNZ (N = 9) were from 2 cultures.Molecular Pain 2009, 5:26 http://www.molecularpain.com/content/5/1/26
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PDTC and QNZ, prevented the enhancement of K currents
induced by GRO/KC. A number of proinflammatory
cytokines, including TNF-α [44], IL-1α [45], IL-6 and cili-
ary neurotrophic factor [46], can activate NF-κB in neu-
rons leading to the altered expression of target genes and
in some cases blocking the apoptosis pathway. CXCR2,
which is the primary GRO/KC receptor in neurons, has
also been shown to activate the NF- κB pathway in cardiac
endothelial cells [47]. To our knowledge, this is the first
report of CXCR2 receptor using this pathway in neurons.
Pannaccione et al [48] demonstrated that NF-κB inhibi-
tors block the increase in mRNA and protein expression of
KV3.4 and its regulatory accessory protein MinK-related
peptide 2, as well as the increase in corresponding K cur-
rents, that are triggered by Aβ peptide exposure in both
PC-12 cells and hippocampal neurons.
Conclusion
On the whole, our data suggest that GRO/KC (CXCL1),
which markedly increases in DRG during the early phase
of several models of pathological pain, has important
effects in inflammatory processes via its direct actions on
sensory neurons, and that activation of NF-κB is involved
in the GRO/KC-induced enhancement of K currents.
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